Clinical Trial Update: Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate Cancer

View source ↗

Summary

This document reports on a completed prospective multicentre non-interventional study evaluating VANTAS for advanced prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• VANTAS

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Prostate Cancer | Status: COMPLETED